Stock NBSE NEUBASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NeuBase Therapeutics, Inc. Nasdaq

Equities

NBSE

US64132K2015

Delayed Nasdaq
Other stock markets
 04:30:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
0.378 USD -3.20% Intraday chart for NeuBase Therapeutics, Inc. -.--% -48.93%
May. 29 NeuBase Therapeutics, Inc. announced that it has received $0.000001 million in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 54.63B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.92B
LONZA GROUP AG Stock Lonza Group AG
 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
 26.22B
  1. Stock Market
  2. Equities
  3. O7P Stock
  4. NBSE Stock
  5. Charts NeuBase Therapeutics, Inc.
  6. Sector Chart